Rectroclavicular Block in Orthopedic Surgey

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-65
SponsorNew Valley University

About this trial

The ultrasound-guided retroclavicular approach to the infraclavicular region (RAPTIR) brachial plexus block has gained popularity as a relatively easy-to-perform nerve block that provides reliable and dense anesthesia to the upper extremity with a single injection. The block has been well described in the anesthesia community since it was first introduced by Hebbard and Royse in 2007 . In 2017, Luftig first described the block's use in the ED setting for a variety of indications . This nerve block has classically been described to provide extensive anesthesia for procedures distal to the shoulder, such as elbow dislocations, distal radius fractures, and surgical procedures.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients undergoing upper limb orthopedic surgery,

Disqualifiers

- Contraindications to regional block (coagulopathy, infection at the needle insertion site, or diaphragmatic paralysis).

Altered conscious level.

Pregnancy.

Body mass index (BMI > 35).

Trial design

Design model

Parallel

Treatments tested in this trial

  • retrocalvicular block

    Other intervention

    retrocalvicular block in upper limb orthopedic Surgey

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: ketamine with bupicavaineActive comparator 1 intervention
Group B: bupicavacine (control group)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

numerical rating pain scale .

0= no pain , 10 = sever pain

Time frame
24 hours

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.